Sources | Names Used |
---|---|
CTRPv2 | Repligen 136 |
PharmacoGx | Repligen 136 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | GRK3 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.01 |
mRNA | CLEC4D | CTRPv2 | pan-cancer | AAC | 0.089 | 0.01 |
mRNA | EID1 | CTRPv2 | pan-cancer | AAC | -0.097 | 0.01 |
mRNA | MARCH4 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.01 |
mRNA | CCM2 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.01 |
mRNA | RBM12B | CTRPv2 | pan-cancer | AAC | 0.094 | 0.01 |
mRNA | PANK3 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.01 |
mRNA | AL078584.1 | CTRPv2 | pan-cancer | AAC | -0.098 | 0.01 |
mRNA | RP1-317E23.6 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.01 |
mRNA | CYBRD1 | CTRPv2 | pan-cancer | AAC | -0.097 | 0.01 |